Early stages of in vitro killing curve of LY146032 and vancomycin for Staphylococcus aureus.
about
Single-dose pharmacokinetics and antibacterial activity of daptomycin, a new lipopeptide antibiotic, in healthy volunteersStaphylococcus aureus ventriculitis treated with single-dose intraventricular vancomycin or daptomycin (LY146032): bacterial and antibiotic kinetics in hydrocephalic rabbitsBactericidal activity of vancomycin in cerebrospinal fluidArbekacin: another novel agent for treating infections due to methicillin-resistant Staphylococcus aureus and multidrug-resistant Gram-negative pathogens.In vivo pharmacodynamic activity of daptomycinAssessment of effects of protein binding on daptomycin and vancomycin killing of Staphylococcus aureus by using an in vitro pharmacodynamic modelComparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determinationEx vivo study of serum bactericidal titers and killing rates of daptomycin (LY146032) combined or not combined with amikacin compared with those of vancomycinMathematical model for comparison of time-killing curves.Pharmacokinetics and bactericidal rates of daptomycin and vancomycin in intravenous drug abusers being treated for gram-positive endocarditis and bacteremia.Investigation of the early killing of Staphylococcus aureus by daptomycin by using an in vitro pharmacodynamic model.Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy.In vitro studies of pharmacodynamic properties of vancomycin against Staphylococcus aureus and Staphylococcus epidermidisIn vitro pharmacodynamic effects of concentration, pH, and growth phase on serum bactericidal activities of daptomycin and vancomycin.The killing effect of cryptolepine on Staphylococcus aureus.
P2860
Q24679375-298FE520-7D00-4B92-A641-A28205A1BD76Q30451719-E7E5C014-64BE-40A6-AD2D-61D44C110B09Q33977378-9243486C-77EC-4297-BC73-B08F1D446034Q34442603-A13CD541-AC0F-4521-97FA-C3D1C7E65C22Q35005549-81660ACE-EBAB-43B9-9223-D77F864BE5C7Q35276965-5DBFB7EF-F257-4D61-89A3-AE70EE0E3559Q35285000-F85F190C-02A1-456F-83AE-CA73F4783500Q35355587-E8EF53C6-95B0-450E-9159-EAE69922512FQ35817983-1CAFA8F8-C450-4F94-89B5-0F3745D49DF2Q35836523-687D1D67-325C-4BCE-9D56-A95267627D83Q36757990-AAAF4946-E2F6-4B30-B6E8-82F293C207B5Q37821604-35793F43-C99A-4591-88E6-2348A74499C7Q39559251-9B1A6D05-6645-4DF1-B9B5-9D4013492F82Q40088863-8FB86732-054D-4D91-BD29-F9821483FFFFQ45197137-784D4A14-C16B-4725-88BB-6DF0A7312E54
P2860
Early stages of in vitro killing curve of LY146032 and vancomycin for Staphylococcus aureus.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
Early stages of in vitro killi ...... cin for Staphylococcus aureus.
@en
Early stages of in vitro killi ...... cin for Staphylococcus aureus.
@nl
type
label
Early stages of in vitro killi ...... cin for Staphylococcus aureus.
@en
Early stages of in vitro killi ...... cin for Staphylococcus aureus.
@nl
prefLabel
Early stages of in vitro killi ...... cin for Staphylococcus aureus.
@en
Early stages of in vitro killi ...... cin for Staphylococcus aureus.
@nl
P2093
P2860
P356
P1476
Early stages of in vitro killi ...... cin for Staphylococcus aureus.
@en
P2093
P2860
P304
P356
10.1128/AAC.32.4.454
P407
P577
1988-04-01T00:00:00Z